array-comparative genomic hybridization (acgh) oligo microarray 4×180k Search Results


90
Agilent technologies sureprint g3 human genome cgh+snp microarray kit
Sureprint G3 Human Genome Cgh+Snp Microarray Kit, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureprint g3 human genome cgh+snp microarray kit/product/Agilent technologies
Average 90 stars, based on 1 article reviews
sureprint g3 human genome cgh+snp microarray kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies sureprint g3 human cgh microarray kit, 4 £ 180k
Sureprint G3 Human Cgh Microarray Kit, 4 £ 180k, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureprint g3 human cgh microarray kit, 4 £ 180k/product/Agilent technologies
Average 90 stars, based on 1 article reviews
sureprint g3 human cgh microarray kit, 4 £ 180k - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies array-comparative genomic hybridization (acgh) oligo microarray 4×180k
Array Comparative Genomic Hybridization (Acgh) Oligo Microarray 4×180k, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array-comparative genomic hybridization (acgh) oligo microarray 4×180k/product/Agilent technologies
Average 90 stars, based on 1 article reviews
array-comparative genomic hybridization (acgh) oligo microarray 4×180k - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies sureprint g3 cgh 4 × 180k microarrays
Sureprint G3 Cgh 4 × 180k Microarrays, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureprint g3 cgh 4 × 180k microarrays/product/Agilent technologies
Average 90 stars, based on 1 article reviews
sureprint g3 cgh 4 × 180k microarrays - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies 4×180k sureprint g3 human cgh microarray
( a ) Overview and design of the experimental procedures. ( b ) Illustration of targeted 16p11.2 rMDS segment and/or SDs. For simplicity, only protein coding genes are shown from the Ensembl GRCh37 V.71 annotation . The targeted unique genomic segment for the dual-guide 575 kb deletion is indicated in yellow, and the single-guide RNA targeting the SDs to promote a model of NAHR-mediated CNV is indicated in red (Target sequence: 5′-ACATGCCTATATCGCATAG -3′, chromosome 16: 29,487,572–29,487,590 and 30,226,917–30,226,935). ( c ) Efficiency of CRISPR/Cas9 generation of the 740 kb rMDS using the single-guide SCORE method that targets the SDs is shown, as determined by copy number screening assay for six genes. Further characterization by <t>microarray</t> and RNAseq was performed for a subset of microdeletion clones (6), and all microduplication clones (5). ( d ) Microarray analyses showing deletion (CRISPR Del) and duplication (CRISPR Dup) of the 16p11.2 region in CRISPR-treated lines is shown. Gains or losses of 16p11.2 region were determined by normalized log2 ratios. No off-target CNVs were observed in CRISPR-generated clones.
4×180k Sureprint G3 Human Cgh Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4×180k sureprint g3 human cgh microarray/product/Agilent technologies
Average 90 stars, based on 1 article reviews
4×180k sureprint g3 human cgh microarray - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Oxford Gene Technology custom designed 4×180k oligonucleotide microarray platform
( a ) Overview and design of the experimental procedures. ( b ) Illustration of targeted 16p11.2 rMDS segment and/or SDs. For simplicity, only protein coding genes are shown from the Ensembl GRCh37 V.71 annotation . The targeted unique genomic segment for the dual-guide 575 kb deletion is indicated in yellow, and the single-guide RNA targeting the SDs to promote a model of NAHR-mediated CNV is indicated in red (Target sequence: 5′-ACATGCCTATATCGCATAG -3′, chromosome 16: 29,487,572–29,487,590 and 30,226,917–30,226,935). ( c ) Efficiency of CRISPR/Cas9 generation of the 740 kb rMDS using the single-guide SCORE method that targets the SDs is shown, as determined by copy number screening assay for six genes. Further characterization by <t>microarray</t> and RNAseq was performed for a subset of microdeletion clones (6), and all microduplication clones (5). ( d ) Microarray analyses showing deletion (CRISPR Del) and duplication (CRISPR Dup) of the 16p11.2 region in CRISPR-treated lines is shown. Gains or losses of 16p11.2 region were determined by normalized log2 ratios. No off-target CNVs were observed in CRISPR-generated clones.
Custom Designed 4×180k Oligonucleotide Microarray Platform, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/custom designed 4×180k oligonucleotide microarray platform/product/Oxford Gene Technology
Average 90 stars, based on 1 article reviews
custom designed 4×180k oligonucleotide microarray platform - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Oxford Gene Technology 4 × 180k custom oligonucleotide microarray
( a ) Overview and design of the experimental procedures. ( b ) Illustration of targeted 16p11.2 rMDS segment and/or SDs. For simplicity, only protein coding genes are shown from the Ensembl GRCh37 V.71 annotation . The targeted unique genomic segment for the dual-guide 575 kb deletion is indicated in yellow, and the single-guide RNA targeting the SDs to promote a model of NAHR-mediated CNV is indicated in red (Target sequence: 5′-ACATGCCTATATCGCATAG -3′, chromosome 16: 29,487,572–29,487,590 and 30,226,917–30,226,935). ( c ) Efficiency of CRISPR/Cas9 generation of the 740 kb rMDS using the single-guide SCORE method that targets the SDs is shown, as determined by copy number screening assay for six genes. Further characterization by <t>microarray</t> and RNAseq was performed for a subset of microdeletion clones (6), and all microduplication clones (5). ( d ) Microarray analyses showing deletion (CRISPR Del) and duplication (CRISPR Dup) of the 16p11.2 region in CRISPR-treated lines is shown. Gains or losses of 16p11.2 region were determined by normalized log2 ratios. No off-target CNVs were observed in CRISPR-generated clones.
4 × 180k Custom Oligonucleotide Microarray, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4 × 180k custom oligonucleotide microarray/product/Oxford Gene Technology
Average 90 stars, based on 1 article reviews
4 × 180k custom oligonucleotide microarray - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

86
WiCell Research Institute Inc heterozygosity analysis
( a ) Overview and design of the experimental procedures. ( b ) Illustration of targeted 16p11.2 rMDS segment and/or SDs. For simplicity, only protein coding genes are shown from the Ensembl GRCh37 V.71 annotation . The targeted unique genomic segment for the dual-guide 575 kb deletion is indicated in yellow, and the single-guide RNA targeting the SDs to promote a model of NAHR-mediated CNV is indicated in red (Target sequence: 5′-ACATGCCTATATCGCATAG -3′, chromosome 16: 29,487,572–29,487,590 and 30,226,917–30,226,935). ( c ) Efficiency of CRISPR/Cas9 generation of the 740 kb rMDS using the single-guide SCORE method that targets the SDs is shown, as determined by copy number screening assay for six genes. Further characterization by <t>microarray</t> and RNAseq was performed for a subset of microdeletion clones (6), and all microduplication clones (5). ( d ) Microarray analyses showing deletion (CRISPR Del) and duplication (CRISPR Dup) of the 16p11.2 region in CRISPR-treated lines is shown. Gains or losses of 16p11.2 region were determined by normalized log2 ratios. No off-target CNVs were observed in CRISPR-generated clones.
Heterozygosity Analysis, supplied by WiCell Research Institute Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/heterozygosity analysis/product/WiCell Research Institute Inc
Average 86 stars, based on 1 article reviews
heterozygosity analysis - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
Agilent technologies 60 k microarray platform
( a ) Overview and design of the experimental procedures. ( b ) Illustration of targeted 16p11.2 rMDS segment and/or SDs. For simplicity, only protein coding genes are shown from the Ensembl GRCh37 V.71 annotation . The targeted unique genomic segment for the dual-guide 575 kb deletion is indicated in yellow, and the single-guide RNA targeting the SDs to promote a model of NAHR-mediated CNV is indicated in red (Target sequence: 5′-ACATGCCTATATCGCATAG -3′, chromosome 16: 29,487,572–29,487,590 and 30,226,917–30,226,935). ( c ) Efficiency of CRISPR/Cas9 generation of the 740 kb rMDS using the single-guide SCORE method that targets the SDs is shown, as determined by copy number screening assay for six genes. Further characterization by <t>microarray</t> and RNAseq was performed for a subset of microdeletion clones (6), and all microduplication clones (5). ( d ) Microarray analyses showing deletion (CRISPR Del) and duplication (CRISPR Dup) of the 16p11.2 region in CRISPR-treated lines is shown. Gains or losses of 16p11.2 region were determined by normalized log2 ratios. No off-target CNVs were observed in CRISPR-generated clones.
60 K Microarray Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/60 k microarray platform/product/Agilent technologies
Average 90 stars, based on 1 article reviews
60 k microarray platform - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies sureprint g3 human cgh+snp 4 × 180k microarray kit
( a ) Overview and design of the experimental procedures. ( b ) Illustration of targeted 16p11.2 rMDS segment and/or SDs. For simplicity, only protein coding genes are shown from the Ensembl GRCh37 V.71 annotation . The targeted unique genomic segment for the dual-guide 575 kb deletion is indicated in yellow, and the single-guide RNA targeting the SDs to promote a model of NAHR-mediated CNV is indicated in red (Target sequence: 5′-ACATGCCTATATCGCATAG -3′, chromosome 16: 29,487,572–29,487,590 and 30,226,917–30,226,935). ( c ) Efficiency of CRISPR/Cas9 generation of the 740 kb rMDS using the single-guide SCORE method that targets the SDs is shown, as determined by copy number screening assay for six genes. Further characterization by <t>microarray</t> and RNAseq was performed for a subset of microdeletion clones (6), and all microduplication clones (5). ( d ) Microarray analyses showing deletion (CRISPR Del) and duplication (CRISPR Dup) of the 16p11.2 region in CRISPR-treated lines is shown. Gains or losses of 16p11.2 region were determined by normalized log2 ratios. No off-target CNVs were observed in CRISPR-generated clones.
Sureprint G3 Human Cgh+Snp 4 × 180k Microarray Kit, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureprint g3 human cgh+snp 4 × 180k microarray kit/product/Agilent technologies
Average 90 stars, based on 1 article reviews
sureprint g3 human cgh+snp 4 × 180k microarray kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies 4 × 180 k cgh oligonucleotide microarray
( a ) Overview and design of the experimental procedures. ( b ) Illustration of targeted 16p11.2 rMDS segment and/or SDs. For simplicity, only protein coding genes are shown from the Ensembl GRCh37 V.71 annotation . The targeted unique genomic segment for the dual-guide 575 kb deletion is indicated in yellow, and the single-guide RNA targeting the SDs to promote a model of NAHR-mediated CNV is indicated in red (Target sequence: 5′-ACATGCCTATATCGCATAG -3′, chromosome 16: 29,487,572–29,487,590 and 30,226,917–30,226,935). ( c ) Efficiency of CRISPR/Cas9 generation of the 740 kb rMDS using the single-guide SCORE method that targets the SDs is shown, as determined by copy number screening assay for six genes. Further characterization by <t>microarray</t> and RNAseq was performed for a subset of microdeletion clones (6), and all microduplication clones (5). ( d ) Microarray analyses showing deletion (CRISPR Del) and duplication (CRISPR Dup) of the 16p11.2 region in CRISPR-treated lines is shown. Gains or losses of 16p11.2 region were determined by normalized log2 ratios. No off-target CNVs were observed in CRISPR-generated clones.
4 × 180 K Cgh Oligonucleotide Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4 × 180 k cgh oligonucleotide microarray/product/Agilent technologies
Average 90 stars, based on 1 article reviews
4 × 180 k cgh oligonucleotide microarray - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
WholeGenome LLC 4×180k wholegenome oligonucleotide microarray
( a ) Overview and design of the experimental procedures. ( b ) Illustration of targeted 16p11.2 rMDS segment and/or SDs. For simplicity, only protein coding genes are shown from the Ensembl GRCh37 V.71 annotation . The targeted unique genomic segment for the dual-guide 575 kb deletion is indicated in yellow, and the single-guide RNA targeting the SDs to promote a model of NAHR-mediated CNV is indicated in red (Target sequence: 5′-ACATGCCTATATCGCATAG -3′, chromosome 16: 29,487,572–29,487,590 and 30,226,917–30,226,935). ( c ) Efficiency of CRISPR/Cas9 generation of the 740 kb rMDS using the single-guide SCORE method that targets the SDs is shown, as determined by copy number screening assay for six genes. Further characterization by <t>microarray</t> and RNAseq was performed for a subset of microdeletion clones (6), and all microduplication clones (5). ( d ) Microarray analyses showing deletion (CRISPR Del) and duplication (CRISPR Dup) of the 16p11.2 region in CRISPR-treated lines is shown. Gains or losses of 16p11.2 region were determined by normalized log2 ratios. No off-target CNVs were observed in CRISPR-generated clones.
4×180k Wholegenome Oligonucleotide Microarray, supplied by WholeGenome LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4×180k wholegenome oligonucleotide microarray/product/WholeGenome LLC
Average 90 stars, based on 1 article reviews
4×180k wholegenome oligonucleotide microarray - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


( a ) Overview and design of the experimental procedures. ( b ) Illustration of targeted 16p11.2 rMDS segment and/or SDs. For simplicity, only protein coding genes are shown from the Ensembl GRCh37 V.71 annotation . The targeted unique genomic segment for the dual-guide 575 kb deletion is indicated in yellow, and the single-guide RNA targeting the SDs to promote a model of NAHR-mediated CNV is indicated in red (Target sequence: 5′-ACATGCCTATATCGCATAG -3′, chromosome 16: 29,487,572–29,487,590 and 30,226,917–30,226,935). ( c ) Efficiency of CRISPR/Cas9 generation of the 740 kb rMDS using the single-guide SCORE method that targets the SDs is shown, as determined by copy number screening assay for six genes. Further characterization by microarray and RNAseq was performed for a subset of microdeletion clones (6), and all microduplication clones (5). ( d ) Microarray analyses showing deletion (CRISPR Del) and duplication (CRISPR Dup) of the 16p11.2 region in CRISPR-treated lines is shown. Gains or losses of 16p11.2 region were determined by normalized log2 ratios. No off-target CNVs were observed in CRISPR-generated clones.

Journal: Nature neuroscience

Article Title: Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR

doi: 10.1038/nn.4235

Figure Lengend Snippet: ( a ) Overview and design of the experimental procedures. ( b ) Illustration of targeted 16p11.2 rMDS segment and/or SDs. For simplicity, only protein coding genes are shown from the Ensembl GRCh37 V.71 annotation . The targeted unique genomic segment for the dual-guide 575 kb deletion is indicated in yellow, and the single-guide RNA targeting the SDs to promote a model of NAHR-mediated CNV is indicated in red (Target sequence: 5′-ACATGCCTATATCGCATAG -3′, chromosome 16: 29,487,572–29,487,590 and 30,226,917–30,226,935). ( c ) Efficiency of CRISPR/Cas9 generation of the 740 kb rMDS using the single-guide SCORE method that targets the SDs is shown, as determined by copy number screening assay for six genes. Further characterization by microarray and RNAseq was performed for a subset of microdeletion clones (6), and all microduplication clones (5). ( d ) Microarray analyses showing deletion (CRISPR Del) and duplication (CRISPR Dup) of the 16p11.2 region in CRISPR-treated lines is shown. Gains or losses of 16p11.2 region were determined by normalized log2 ratios. No off-target CNVs were observed in CRISPR-generated clones.

Article Snippet: Array-based comparative genomic hybridization (aCGH) was performed on the Agilent 4×180K SurePrint G3 Human CGH Microarray (Design #022060) according to the protocol provided by the manufacturer.

Techniques: Sequencing, CRISPR, Screening Assay, Microarray, Clone Assay, Generated